EDIT - Wall Street Estimates - Editas Medicine, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.22

-1.61 %

$ 101 M

Market Cap

-0.48

P/E

Price Target Average

661.12%

Revenue Forecast Estimate

--7.59%

EBIT Estimate

28.57%

Net Income Estimate

18.48%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Editas Medicine, Inc.

Wall Street analysts predict an average 1-year price target for EDIT of $9.29 , with forecasts ranging from a low of $5 to a high of $15 .

EDIT Lowest Price Target Wall Street Target

5 USD 309.84%

EDIT Average Price Target Wall Street Target

9.29 USD 661.12%

EDIT Highest Price Target Wall Street Target

15 USD 1129.51%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free